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OBJECTIVE—Therapeutic footwear for diabetic foot patients aims to reduce the risk of ul-
cerationbyrelievingmechanicalpressureonthefoot.However,footwearefﬁcacyisgenerallynot
assessed in clinical practice. The purpose of this study was to assess the value of in-shoe plantar
pressure analysis to evaluate and optimize the pressure-reducing effects of diabetic therapeutic
footwear.
RESEARCHDESIGNANDMETHODS—Dynamicin-shoeplantarpressuredistribution
was measured in 23 neuropathic diabetic foot patients wearing fully customized footwear.
Regions of interest (with peak pressure .200 kPa) were selected and targeted for pressure
optimization by modifying the shoe or insole. After each of a maximum of three rounds of
modiﬁcations, the effect on in-shoe plantar pressure was measured. Successful optimization
was achieved with a peak pressure reduction of .25% (criterion A) or below an absolute level
of 200 kPa (criterion B).
RESULTS—In35deﬁnedregions,meanpeakpressurewassigniﬁcantlyreducedfrom303(SD
77)to208(46)kPaafteranaverage1.6roundsoffootwearmodiﬁcations(P,0.001).Thisresult
constitutes a 30.2% pressure relief (range 18–50% across regions). All regions were successfully
optimized: 16 according to criterion A, 7 to criterion B, and 12 to criterion A and B. Footwear
optimization lasted on average 53 min.
CONCLUSIONS—Theseﬁndingssuggestthatin-shoeplantarpressureanalysisisaneffective
and efﬁcient tool to evaluate and guide footwear modiﬁcationsthatsigniﬁcantly reduce pressure
in the neuropathic diabetic foot. This result provides an objective approach to instantly improve
footwear quality, which should reduce the risk for pressure-related plantar foot ulcers.
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A
s a long-term complication of the
disease, foot ulceration poses a sig-
niﬁc a n tb u r d e no np a t i e n t sw i t h
diabetes. Foot ulcers are an important
precursor to infection and amputation
(1,2). Approximately half of diabetic foot
ulcers occur on the plantar surface of the
foot (3). Peripheral neuropathy and in-
creased levels of mechanical foot pressure
are important factors in the cause of
plantar foot ulceration (4,5). Therapeutic
footwear is often prescribed to prevent
ulceration, particularly for patients who
have suffered prior ulceration. The foot-
wear’s primary goal is to redistribute pres-
sure on the plantar foot surface to relieve
pressure at locations that are at risk for
(re)ulceration.
When evaluating the efﬁcacy of ther-
apeutic footwear in patients with neuro-
pathic foot problems, patient feedback is
inadequate because of the presence of
neuropathy. Mostly, a trial-and-error ap-
proach with subsequent inspection of the
feet is used. Eventually, feedback consists
of the information on whether the patient
remains free of ulceration. Objective
methods to evaluate the footwear, such
as in-shoe plantar pressure analysis, are
not regularly used in clinical practice,
despite the fact that the footwear’sp r i -
mary goal is to relieve pressure. Addi-
tionally, the pressure-relieving effect of
footwear interventions is difﬁcult to pre-
dictatthe individualpatientlevelbecause
of the variability in outcomes (6–9). This
result prevents establishing guidelines for
effectivefootwearprescriptionsand mod-
iﬁcation and argues for the use of in-shoe
plantar pressure assessment for evaluat-
ing individual patients (6,10–13).
Within this context, in-shoe plantar
pressure assessment may have the addi-
tional potential to guide modiﬁcations in
the footwear to achieve a more optimal
solution (in terms of pressure reduction)
(10,14). If successful, such optimization
will reduce the variability in outcome of
footwear prescriptions and further sup-
port the use of in-shoe pressure analysis
in clinical practice. Therefore, the pur-
pose of this study was to assess the value
of using in-shoe plantar pressure analy-
sistoevaluateandoptimizethepressure-
reducing effects of therapeutic footwear
in neuropathic diabetic foot patients.
RESEARCH DESIGN AND
METHODS
Subjects
A total of 23 neuropathic diabetic foot
patients participated (17 men, 6 women).
Mean age was 59.1 (SD 12.6) years, and
mean BMI was 33.0 (8.7) kg/m
2.E i g h t
patients had type 1 diabetes, and 15 had
type2diabetes.Meandurationofdiabetes
was 13.8 (10.1) years, and mean HbA1c
level was 7.3 (1.1) percent. A total of
18 patients had a history of plantar foot
ulceration, which included nontraumatic
neuropathic foot ulcers located at the
hallux (n = 3), toes (n = 1), metatarsal
heads (n = 11), or midfoot (n = 3). All
patients had at least one foot deformity
ccccccccccccccccccccccccccccccccccccccccccccccccc
Fromthe
1DepartmentofRehabilitation,AcademicMedicalCenter,UniversityofAmsterdam,Amsterdam,the
Netherlands; and the
2Diabetic Foot Unit, Department of Surgery, Ziekenhuisgroep Twente, Almelo, the
Netherlands.
Corresponding author: Sicco A. Bus, s.a.bus@amc.uva.nl.
Received 24 November 2010 and accepted 20 April 2011.
DOI: 10.2337/dc10-2206
© 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited,theuseiseducationalandnotforproﬁt,andtheworkisnotaltered.Seehttp://creativecommons.org/
licenses/by-nc-nd/3.0/ for details.
care.diabetesjournals.org DIABETES CARE, VOLUME 34, JULY 2011 1595
Emerging Treatments and Technologies
ORIGINAL ARTICLE(claw/hammer toes, hallux valgus, mid-
foot Charcot deformity, limited joint
mobility, pes planus, or pes cavus). Pe-
ripheral neuropathy was conﬁrmed by
the inability to feel the pressure of a
10-g Semmes-Weinstein monoﬁlament
at one or more of six plantar foot sites.
Patients from four different outpa-
tient clinics were included. Two clinics
provided four participating patients, one
clinic six patients, and one clinic nine
patients. All participants were consec-
utive referrals for footwear evaluation
because of previous ulcer healing, the
presence of severe deformity, or presigns
of ulceration and a measured in-shoe
plantar pressure .200 kPa. The study
was conducted as a noninterventional
study in a patient care setting. For this
reason, the local ethics committee waived
the requirement for ethical approval of
the study.
Footwear and instrumentation
The prescribed therapeutic footwear con-
sistedoffullycustomizedfootwear(n=22 )
or custom molded insoles in an extra-
depth shoe (n = 1). Nine patients wore
new footwear, and 14 patients wore pre-
viously delivered footwear. The overall
mean age of the tested footwear was 2.3
months. The footwear was generally man-
ufactured on a last that was created from a
negative or positive cast or foam impres-
sionofthepatient’sfoot.Blueprintsand/or
glass-plate images of the feet were used to
identify foot shape and speciﬁca t - r i s k
locations to target footwear design and
manufacturing. Shoes were mostly ankle
high and made from leather with a stiff-
ened rubber outsole and roller conﬁgura-
tion. Custom molded insoles were made
from multidensity-layered materials,
w i t ham o l d a b l eb a s ea n da no p e no r
closed-cell material top cover. Patients
wore their own socks, which were mostly
thin seamless socks. The footwear in each
clinic was prescribed and manufactured
by a rehabilitation specialist and an ortho-
pedic shoe technician (qualiﬁcation simi-
lar to a certiﬁed pedorthist) who had a
minimum of 4 years’ experience with
treating the diabetic foot.
In-shoe plantar pressures were mea-
sured using the Pedar-X system (Novel,
Munich,Germany).Thissystemcomprises
2-mm-thick ﬂexible pressure-sensing in-
solesincluding99sensorseachmeasuring
the vertical (normal) pressure at the shoe-
sock interface at a sample frequency of
50Hz.Pedar-wideinsoleswereavailablein
ﬁve different length sizes to accommodate
different foot sizes. Before the pressure
measurements, each of the 99 individual
sensors per insole was calibrated accord-
ing to the manufacturer’s guidelines.
Protocol and footwear optimization
Patients repeatedly walked at a self-
selected speed along a 12-m walkway
while in-shoe plantar pressures were mea-
sured.Witheachpressuremeasurement,a
minimum of 15 midgait steps were col-
lected in four walking trials. Walking
speed was measured between two ﬁxed
points using a stopwatch and kept con-
stant between trials (maximum 5% de-
viation).
The footwear optimization algorithm
is shown in Fig. 1. In-shoe plantar pres-
sures were ﬁrst measured in the non-
modiﬁed footwear (baseline assessment).
From the peak pressure distribution dia-
grams shown on-screen in the Novel step
analysis program, regions of interest
(ROIs) were deﬁned as target regions for
pressure optimization. These ROIs cor-
responded with locations of previous ul-
ceration, severe foot deformity (Charcot
osteoarthropathy), or preulcerative signs,
all in which the measured peak pressure
was .200 kPa. Other regions showing
peak pressures .300 kPa were also
targeted. A maximum of three ROIs per
foot were selected.
The shoe technician modiﬁed the
footwear with the goal to reduce peak
pressureattheROI.Necessary machinery
and materials were available at the testing
site.Thechoiceofmodiﬁcationwasmade
by the shoe technician and/or physician
and consisted of the local removal or
softeningofmaterialintheinsole;replace-
ment of the insole top cover; the addition
of a metatarsal pad, hallux pad, or meta-
tarsal bar in the insole; or the adjustment
of the rocker or roller in the shoe outsole
or insole (i.e., earlier or more signiﬁcant).
Morethan one footwear modiﬁcationwas
allowed at the same time. Modiﬁcations
that would require signiﬁcant extra time
or special machinery such as the applica-
tion of a new rocker outsole or the re-
placement of midsole materials were not
applied.
Footwear modiﬁcation was directly
followedbyanin-shoepressuremeasure-
ment.Walkingspeedwaskeptconsistent
with the speed measured during baseline
assessment (maximum 5% deviation).
Change in peak pressure at the ROI com-
pared with baseline was calculated from
the on-screen display of the peak pres-
sure diagrams.
The footwear was classiﬁed as suc-
cessfullyoptimizedwhen,comparedwith
the baseline assessment, a minimum 25%
reduction in mean peak pressure at the
ROI was achieved (criterion A) or mean
peak pressure was reduced below an
absolute level of 200 kPa (criterion B).
Both criteria were chosen to represent a
signiﬁcant, probably clinically relevant,
reduction in plantar pressure. Criterion B
was based on previous results showing an
averagein-shoepeakpressureof;200kPa
using similar equipment in patients who
had remained healed in their prescribed
footwearafteranepisodeofulceration(15).
I ft h eo p t i m i z a t i o nc r i t e r i aw e r en o t
met after the ﬁrst round of one or more
modiﬁcations, additional in-shoe pres-
sure evaluations and modiﬁcations were
allowed, up to a maximum of three rounds.
This number of modiﬁcation rounds was
maximized for feasibility reasons consid-
ering the (potential) use of this approach
in clinical practice. If the optimization cri-
teria were not met within three rounds,
optimization was considered a failure. The
time required to complete the session, in-
cluding all pressure measurements and
footwear modiﬁcations, was recorded.
Data analysis
Using Novel multimask software, masks
were drawn for each ROI and, in the same
foot,foreachof10anatomicalfootregions:
medial and lateral heel, medial and
lateralmidfoot,metatarsal1,metatarsals
2/3, metatarsals 4/5, hallux, toes 2/3, and
toes 4/5. For each mask, mean peak pres-
sure and pressure-time integral over all
collected steps per foot were calculated.
Figure 1—Schematic diagram of the footwear
optimization algorithm used in the study. PP,
peak pressure.
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Pressure optimization in therapeutic footwearSpeciﬁc analyses were performed for each
ROI, for each major foot location where
the ROI were present (hallux, metatarsals,
andmidfoot),foreachshoetechnician,for
new and already worn footwear, and for
each type of modiﬁcation applied. When
more than one modiﬁcation was made in
thesameroundoffootwearmodiﬁcations,
the effect of these modiﬁcations on peak
pressure was considered evenly distrib-
uted. Peak pressure effects in neighboring
(anatomical) regions of each ROI after
modifying the footwear were calculated
andconsideredexcessiveifincreased.25
kPa and .25% compared with baseline.
Where data were compared statistically,
paired t tests or ANOVA were conducted
in SPSS (version 16.0).
RESULTS—A total 35 ROIs were se-
lected for footwear optimization. A total
of 17 were located at the metatarsal heads
(ﬁrst, n =6 ;s e c o n do rt h i r d ,n =9 ;ﬁfth,
n = 2), 13 at the hallux, and 5 at the mid-
foot. In 9 of the 18 patients who had a
previous foot ulcer, the ROI corresponded
with the previous ulcer location.
All 35 ROIs could be optimized ac-
cording to the deﬁned criteria: 16 on the
basis of a minimum 25% peak pressure
relief compared with baseline, 7 on the
basisofapeakpressurereductionbelowa
level of 200 kPa, and 12 on the basis of
both criteria. The mean peak pressure
measured at baseline in all ROIs was 303
(SD 77) kPa. Peak pressure signiﬁcantly
reduced with 95 kPa (30.2%, P , 0.001)
to a mean 208 (SD 46) kPa after all nec-
essary rounds of footwear modiﬁcation.
The range in peak pressure relief across
individual ROI was 17.1–51.8%. Mean
relief in pressure-time integral across all
ROIs after modifying the footwear was
24.3% (P , 0.001). The mean time re-
quired to complete the testing session
was 53 min (SD 13, range 34–78).
An average 1.6 rounds of footwear
modiﬁcations were needed to satisfy the
optimization criteria. In the 21 ROIs re-
quiring one round, mean peak pressure
relief compared with baseline was 30.3%.
In the seven ROIs requiring two rounds,
mean peak pressure relief was 9.2% after
theﬁrstroundand23.0%afterthesecond
round. In the seven ROIs requiring three
rounds, mean peak pressure relief was
10.6% after the ﬁrst, 1.7% after the
second, and 18.5% after the third round.
Figure2showsthepeakpressurechanges
perfollow-upin-shoepressuremeasure-
ment together with the applied modi-
ﬁcations in each round of footwear
modiﬁcation for all 35 individual ROIs.
Peakpressurediagramsforapatientwho
had his footwear successfully optimized
are also shown in Fig. 2.
There were no signiﬁcant differences
in mean peak pressure relief achieved
between the ROI optimized by the four
shoe technicians (range 26.7–32.8%, P =
0.37). There were also no signiﬁcant
differences in mean peak pressure relief
achieved between the ROI located at dif-
ferent major foot locations: 33.4% (range
17.6–51.8) for the hallux (n =1 3R O I ) ,
27.9% (17.2–38.2) for the metatarsal re-
gions(n=17),and29.7%(17.1–40.0)for
the midfoot (n =5 )( P = 0.23). Analysis of
the 10 anatomical foot locations showed
signiﬁcant mean peak pressure reduc-
tions after modifying the footwear in all
but three locations (lateral midfoot, toes
2/3, and toes 2/5) (P , 0.05). Excessive
buildup of pressure in a neighboring re-
gion was present with three of the 35
ROIs.
Five different types of footwear mod-
iﬁcations were used in the study. Their
frequency distribution and mean effects
on peak pressure are shown in Table 1.
Differences in effects between the types of
modiﬁcation were small and nonsigniﬁ-
cant (P = 0.64). Additionally, there was
no clear difference in the type of modiﬁ-
cationsusedand theoptimizationsuccess
between newly delivered and already
worn shoes (mean peak pressure relief
28.5 and 31.3%, respectively).
CONCLUSIONS—The results of this
study showed a substantial relief in
peak pressure of ;30% at selected high-
pressure ROIs after modifying the custom-
made footwear of neuropathic diabetic
foot patients using in-shoe plantar pres-
sure analysis as a guidance tool to the
modiﬁcations made. All selected ROIs
were optimized according to the deﬁned
optimizationcriteria,withinanaverageof
53 min. This result demonstrates in our
view the success and feasibility of the ap-
proach. Because an increase in plantar
foot pressure increases the risk for dia-
betic foot ulceration, such optimization
resultsshouldreducetheriskoffootulcer-
ation. However, this effect remains to be
investigated in a prospective clinical trial.
The study results substantiate earlier
casereportsshowingthatsigniﬁcantpres-
sure relief is achievable when using in-
shoe pressure analysis as a guidance tool
for footwear modiﬁcation (14). Further-
more,theresultssupportearliersuggestions
that in-shoe plantar pressure analysis
should be an integral part of footwear
evaluation in high-risk neuropathic dia-
betic patients (6,10,11,13,16). The ap-
proach offers an individual-based solution
to instantly achieve more optimal footwear
on the assumption that different footwear
design principles or modiﬁcations may
work for different patients. This result is
supported by the ﬁnding that not all ROIs
were optimized within one round or with
one type of footwear modiﬁcation, but re-
quired subsequent rounds and/or different
modiﬁcations to achieve the desired out-
come (Fig. 2). The result is less variability
in outcome on pressure relief across indi-
vidual patients. This provides the clinical
team with a valuable approach to achieve
better quality footwear for the individual
patient.
Atbaseline,thepatients’footwearwas
not yet optimal in relieving pressure,
although half of the previous ulcer loca-
tions were not selected as an ROI, appar-
ently showing already good pressure
relief at these locations. The suboptimal
footwear is probably due to the lack of
available (evidence-based) guidelines for
footwear prescription and lack of predict-
able effects of footwear design principles.
This scenario currently makes the provi-
sion and evaluation of footwear largely a
trial-and-error process, where the skills
and experience of the clinical team deter-
mine the outcome. However, the lack of
differences found in outcome between
the four teams of physicians/shoe techni-
cians suggest that positive results can be
achieved by any experienced team. Only
recently, quantitative approaches such as
t h eu s eo fd y n a m i cb a r e f o o tp r e s s u r er e -
cordings and three-dimensional foot
shape measurements have been intro-
duced in the provision of footwear for di-
abetic patients. The application of such
methodscanresultinfootwearproviding
also an ;30% pressure relief compared
with footwear made using conventional
methods (17). Combining these methods
withthecurrentoptimizationapproachmay
potentiallyfurtheroptimizethepressure-
relieving capacityofprescribedtherapeutic
footwear. This scenario should be tested in
future studies.
Five different types of modiﬁcations
were applied, and all ﬁve were commonly
used. The effect of these modiﬁcations on
peak pressure was quite variable from
ROI to ROI (Table 1, Fig. 2), conﬁrming
the lack of predictability of these modiﬁca-
tions in individual cases. This result sup-
portstheuseoftheoptimizationapproach,
in particular, because of its ﬂexibility to
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Bus, Haspels, and Busch-Westbroekallow multiple (rounds of) modiﬁcations
toincreasethechanceforasigniﬁcantpos-
itiveresult.AverageeffectsattheROIwere
quite similar between different types of
modiﬁcation (;10–15% pressure relief),
showing that all had relevance in opti-
mizing the footwear. Most modiﬁcations
correct the foot and redistribute pressure
from the ROI to neighboring regions. Ex-
cessive buildup of pressure in these neigh-
boring regions should be prevented. In the
feet of only 3 of the 35 ROIs optimized,
a neighboring region showed excessive
pressure buildup. Additionally, in 7 of
10 anatomical locations of the foot, peak
pressure was signiﬁcantly reduced after
modifying the footwear. These results sug-
gest that footwear modiﬁcation did not put
neighboring regions at risk and generally
resulted in a more optimal solution for the
whole foot.
The use of in-shoe plantar pressure
analysis for evaluation and optimization
ofdiabeticfootwearrequires(extra) invest-
ments in machinery, measurement equip-
ment, personnel, and training. These
investments may not be possible at every
treatment location, but specialized centers
should consider adopting such an ap-
proach. In Germany, requirements for
demonstrated efﬁcacy of footwear pre-
scriptions in reducing plantar pressures
have recently been introduced, although
it is unclear which guidelines or evidence
supports these requirements. A proven
cost-effective prevention of foot ulcera-
tion and other complications, using this
approach will stimulate its implementa-
tion in clinical practice and help establish
evidence-based guidelines. Nonetheless,
theapproachshouldbeconsideredrelative
to other foot ulcer prevention strategies
(e.g., diabetes control, podiatry, vascular
control, early recognition of preulcerative
signs). Also, other factors may be impor-
tantindeterminingclinicaloutcomesuch
as shear, duration of pressure, and treat-
ment adherence, although their role has
notbeenstudiedtodate.Wearecurrently
investigating the (cost) effectiveness of the
currentoptimizationapproachand several
of these additional factors in preventing
secondary ulceration in a multicenter ran-
domized controlled trial.
Several aspects of this study should
be considered. First, the outcomes reﬂect
to a certain extent the skills and experi-
ences of the physicians and shoe techni-
cians in modifying the footwear, which
may affect the reproducibility of the
results. Modiﬁcations were not deter-
mined objectively and systematically on
thebasisofacertainpressuredistribution
Figure 2—A–C: Line graphs showing, for each ROI per foot location, the change in peak pressure from baseline to follow-up in-shoe pressure
measurement as a result of each round of footwear modiﬁcation. Also shown for each ROI, as cross outs of the line graphs, are the modiﬁcations
applied,where1)denotesthelocalremovalofmaterialintheinsole,2)thelocalsofteningofmaterialintheinsole,3)thereplacementofthetopcover
oftheinsole,4)theadditionofametatarsalorhalluxpadorbarintheinsole,and5)anearlierormoresigniﬁcantrockerorrollerintheshoeoutsole
or the insole. D: Peak pressure isobar diagrams showing the mean peak pressure measured over multiple steps in the right foot in a tested patient at
baseline (1) and after three rounds of footwear modiﬁcations (2–4). This patient had limited mobility at the ﬁrst metatarsal phalangeal joint and
a history of ulceration at the plantar hallux. He wore fully customized therapeutic footwear. The hallux region was selected as an ROI for pressure
optimization. Footwear modiﬁcations used (and their effect on mean peak pressure in kPa) were as follows: round 1: addition of a hallux bar just
distaltotheﬁrstmetatarsalheadintheinsole(250kPa);round2:applicationofanearlierrollerintheshoeoutsole(228kPa);andround3:replacement
of the top layer of the insolewith 3-mm-thick 32si li c o n efo a m( 270kPa).Totalreductioninmeanpeakpressureatthehalluxwas148kPaor32%.The
diagramsshowatypicalpatternforthestudyﬁnding that footwear modiﬁcationdidnotleadtoexcessivebuildupofpeakpressureinneighboringregions,
but rather to a peak pressure decrease across foot regions.
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Pressure optimization in therapeutic footwearproﬁle because guidelines on how to
reduce these pressures do not exist. We
followed the dominant current practice
in footwear evaluation in which a trial-
and-error approach is used. Nevertheless,
logical choices were made in modifying
the footwear using a limited set of gen-
erally effective modiﬁcations, which re-
sulted, after one or more rounds, in
optimized footwear. Differences in opti-
mization results were not found between
shoe technicians. For these reasons, re-
producibility of the results may still be
quite high. Second, the optimization
criteria were chosen somewhat arbi-
trarily. They were based on what we
considered a clinically relevant pressure
reduction, partly on the basis of previous
recommendations (15), which could be
achieved in a reasonable time. Neverthe-
less, future research will have to show
whether these chosen criteria are clini-
cally meaningful. Third, the number of
tested patients could be considered quite
smallgiventhevariabilityinpressuredis-
tribution proﬁles and footwear modiﬁca-
tions applied. However, all 35 selected
ROI were optimized, and percentage
peak pressure reductions in the ROIs
were signiﬁcantly skewed toward the
positive side (17–52%). On the basis of
these consistent results, we believe that
relevant conclusions can be drawn from
this small study sample. Finally, the
majority of footwear tested (14 of 23) was
previously worn for some period. This
concerned mostly footwear in which pa-
tients had developed an ulcer and which
was modiﬁed after the healing of the ulcer
in another device. Wear and tear of this
footwear may have increased the chance
for successful optimization, although the
results show no clear differences in types
of modiﬁcations used and pressure relief
achieved between the new and already-
worn footwear. The results show that eval-
uation and optimization is worthwhile in
footwear of any age, but the most appropri-
ate moment is probably close to delivery.
Future studies will have to demonstrate the
optimization success in a larger sample of
newly prescribed footwear and the optimal
frequency for in-shoe pressure evaluation.
Inconclusion,theresultsofthisstudy
show that custom-made therapeutic foot-
wear of at-risk neuropathic diabetic foot
patients can be effectively and efﬁciently
optimizedforitspressure-relievingcapacity
when using in-shoe plantar pressure anal-
ysis as a tool to guide modiﬁcations to the
footwear. This provides the clinical team
with a valuable, objective, and efﬁcient
methodtoassess andimprove therapeutic
footwearqualityforindividualpatients.Such
optimization should reduce the risk of
plantarfootulcerationinthispatientgroup,
although this result will have to be con-
ﬁrmed in future prospective clinical trials.
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